Selvita S.A. (WSE:SLV)

Poland flag Poland · Delayed Price · Currency is PLN
34.30
-0.70 (-2.00%)
Apr 28, 2026, 5:00 PM CET
3.94%
Market Cap 629.59M
Revenue (ttm) 371.13M
Net Income (ttm) 813.00K
Shares Out 18.36M
EPS (ttm) 0.04
PE Ratio 774.41
Forward PE 27.66
Dividend n/a
Ex-Dividend Date n/a
Volume 18,864
Average Volume 68,270
Open 35.00
Previous Close 35.00
Day's Range 34.00 - 35.20
52-Week Range 26.50 - 49.40
Beta 0.15
RSI 47.89
Earnings Date Mar 31, 2026

About Selvita

Selvita S.A. operates as a contract research organization worldwide. The company offers drug discovery services in the areas of AI-driven drug discovery, antibody drug discovery, structural biology, recombinant protein production, assay development and screening, computer-aided drug design, medicinal and synthetic chemistry, scale-up, ADME/DMPK, in vitro and In Vivo pharmacology, translational research, and toxicology. It also develops drugs for therapeutic areas, such as oncology, infectious diseases, immunology, neurology, respiratory, and ot... [Read more]

Sector Healthcare
Founded 2007
Employees 691
Stock Exchange Warsaw Stock Exchange
Ticker Symbol SLV
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.